{"id":1697,"date":"2018-12-07T15:45:11","date_gmt":"2018-12-07T15:45:11","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=1697"},"modified":"2018-12-07T15:45:36","modified_gmt":"2018-12-07T15:45:36","slug":"valsartan-recall-widens","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","title":{"rendered":"Valsartan recall widens"},"content":{"rendered":"

The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).<\/p>\n

Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some Valsartan products were contaminated. Legal cases<\/strong><\/a> are already underway, and this latest recall involves further batches of the product.<\/p>\n

An immediate suspension and quarantine of the additional affected products has been ordered.<\/p>\n

<\/p>\n

About the Valsartan recall operations across the world<\/strong><\/h3>\n

Valsartan recall operations are taking place across the world after dangerous contaminates had been identified in products.<\/p>\n

Some of the products have been contaminated by NDMA (nitrosodimethylamine) and NDEA (N\u2011nitrosodiethylamine). Both are genotoxic with carcinogenic properties.<\/p>\n

In other words, they can be very dangerous for humans.<\/p>\n

Patients have been asked to stop taking medication from affected batches immediately. There can be serious risks from stopping the medication, so patients are being urged to seek advice as soon as they can. Replacement medication will need to be issued as opposed to stopping the medication altogether.<\/p>\n

The UK\u2019s MHRA is said to be working with its European and worldwide counterparts over the Valsartan recall operations.<\/p>\n

Valsartan recall operation in UK<\/strong><\/h3>\n

The Valsartan recall operation in the UK was a Class 1 medication recall over summer when the issue first emerged. Pharmacists were asked to immediately suspend issuance of the drugs and quarantined affected batches. Suppliers were then to be contacted for replacements.<\/p>\n

Since then, investigations into whether the initial Valsartan recall needed to be widened have been taking place. The latest from the MHRA is that the recall has been widened after additional contaminates were identified in further batches.<\/p>\n

It does without saying that if anyone suffers as a result of contaminated medication, they must seek medical and legal help immediately<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA). Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some … Continue reading Valsartan recall widens<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1539,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[36,5,27,10],"tags":[4,16,60,61,46,20,24,55,8],"class_list":["post-1697","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-medical","category-products","category-recalls","tag-compensation-claims","tag-investigations","tag-medical-product","tag-medical-recall","tag-medicinal-drugs","tag-mhra","tag-prescription-drugs","tag-product-safety","tag-recalls"],"yoast_head":"\nValsartan recall widens - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valsartan recall widens - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-07T15:45:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-12-07T15:45:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Valsartan recall widens\",\"datePublished\":\"2018-12-07T15:45:11+00:00\",\"dateModified\":\"2018-12-07T15:45:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens\"},\"wordCount\":318,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/cancer-drug-recall.png?fit=1200%2C414&ssl=1\",\"keywords\":[\"compensation claims\",\"investigations\",\"medical product\",\"medical recall\",\"medicinal drugs\",\"mhra\",\"prescription drugs\",\"product safety\",\"recalls\"],\"articleSection\":[\"Health\",\"Medical\",\"Products\",\"Recalls\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens\",\"name\":\"Valsartan recall widens - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/cancer-drug-recall.png?fit=1200%2C414&ssl=1\",\"datePublished\":\"2018-12-07T15:45:11+00:00\",\"dateModified\":\"2018-12-07T15:45:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/cancer-drug-recall.png?fit=1200%2C414&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/cancer-drug-recall.png?fit=1200%2C414&ssl=1\",\"width\":\"1200\",\"height\":\"414\",\"caption\":\"drug recall\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/valsartan-recall-widens#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valsartan recall widens\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valsartan recall widens - Group Action Lawyers","description":"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","og_locale":"en_GB","og_type":"article","og_title":"Valsartan recall widens - Group Action Lawyers","og_description":"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","og_site_name":"Group Action Lawyers","article_published_time":"2018-12-07T15:45:11+00:00","article_modified_time":"2018-12-07T15:45:36+00:00","og_image":[{"width":1200,"height":414,"url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1","type":"image\/png"}],"author":"Author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Valsartan recall widens","datePublished":"2018-12-07T15:45:11+00:00","dateModified":"2018-12-07T15:45:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens"},"wordCount":318,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1","keywords":["compensation claims","investigations","medical product","medical recall","medicinal drugs","mhra","prescription drugs","product safety","recalls"],"articleSection":["Health","Medical","Products","Recalls"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","name":"Valsartan recall widens - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1","datePublished":"2018-12-07T15:45:11+00:00","dateModified":"2018-12-07T15:45:36+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1","width":"1200","height":"414","caption":"drug recall"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Valsartan recall widens"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1","jetpack-related-posts":[{"id":1750,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/are-you-suffering-with-valsartan-side-effects","url_meta":{"origin":1697,"position":0},"title":"Are you suffering with valsartan side effects?","author":"Author","date":"25th March 2019","format":false,"excerpt":"If you\u2019re suffering with valsartan side effects, you may want to read this article and take heed of some important information about the drug. Last year, a Class 1 Medicines Recall was initiated by Medicines and Healthcare products Regulatory Agency (MHRA). The recall stems from potential contamination that comes from\u2026","rel":"","context":"In "Latest"","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"drugs alert","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1652,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","url_meta":{"origin":1697,"position":1},"title":"Latanoprost Timolol eye drops recall","author":"Author","date":"7th September 2018","format":false,"excerpt":"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA). The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an \u2018out of specification result for an unknown impurity\u2019 that was identified during testing.\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"eye claims","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":1697,"position":2},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3187,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","url_meta":{"origin":1697,"position":3},"title":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall","author":"Author","date":"28th October 2025","format":false,"excerpt":"A recall of Flutiform 250 micrograms \/ 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA. The Group Action Lawyers specialises\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"incorrect dose content statement","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1681,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/bone-cement-complications-from-product-recall","url_meta":{"origin":1697,"position":4},"title":"Bone cement complications from product recall","author":"Author","date":"9th November 2018","format":false,"excerpt":"A regulator warning earlier this year stemmed from bone cement complications caused by an issue with the product itself. A risk of the need for revision surgery from the use of Optipac 40 Refobacin Revision and Optipac 80 Refobacin Revision was identified. Manufacturer, Biomet UK Limited, issued a Field Safety\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"medical device recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/zimmer-biomet-recall.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":1632,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/phenytoin-90mg-5ml-oral-suspension-immediate-discontinuation","url_meta":{"origin":1697,"position":5},"title":"Phenytoin 90mg\/5ml Oral Suspension immediate discontinuation","author":"Author","date":"19th July 2018","format":false,"excerpt":"There has been an immediate discontinuation of unlicensed medicine Phenytoin 90mg\/5ml Oral Suspension and a recall of the product. The medication, manufactured by Rosemont Pharmaceuticals Limited, is now no longer on the shelves having been recalled and discontinued with immediate affect as a result of worrying data that suggested that\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"unsatisfactory safety information","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/medical-device-alert.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/medical-device-alert.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/medical-device-alert.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/medical-device-alert.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/medical-device-alert.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=1697"}],"version-history":[{"count":1,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1697\/revisions"}],"predecessor-version":[{"id":1698,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1697\/revisions\/1698"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/1539"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=1697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=1697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=1697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}